Copyright @Medicare Insight

DSM completes acquisition of Glycom and accelerates its leadership in the Early Life Nutrition market

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces the completion of its acquisition of Glycom A/S (“Glycom”), the world’s leading supplier of Human Milk Oligosaccharides (HMOs). The acquisition of Glycom was first announced on 21 February 2020.

 

DSM is a leading global solutions provider to the  and Dietary Supplement industries with a unique portfolio including nutritional lipids, vitamins and custom nutrient premixes. With the acquisition of Glycom, DSM furthers its leadership in the Early Life Nutrition and Dietary Supplement space.

 

HMOs are the third largest solid component of human milk after fat and lactose. Naturally occurring in human breast milk, they have evolved over thousands of years, providing us with unique health benefits. In particular, they support  both immune and cognitive development. There is significant interest in HMO use as a dietary supplement and potentially in food & beverage and pet food applications, and in fulfilling unmet medical nutrition needs, such as irritable bowel syndrome.

 

Glycom is a major pioneer in HMOs, with a rich, science-backed product pipeline, and as the only one, a fully integrated HMO production facility in the world.  It has its own product development, preclinical and clinical programs, regulatory team, as well as large-scale production in its state-of-the-art manufacturing plant in Esbjerg (Denmark).  Next-generation HMOs are part of Glycom’s exciting innovation roadmap, with four new HMOs becoming available this year to further catalyze the already fast-growing HMO market.

 

“We warmly welcome the Glycom team to DSM and are proud to call this professional team our colleagues. Together, we will make it possible for our customers to develop efficacious and safe solutions,  which is the fundament of both Glycom and DSM values and a part of our promise to help keep the world’s growing population healthy”, says Jeremy Xu, President of DSM’s Human Nutrition and Health

 

Odd Hansen, CEO of Glycom, continued: “Today is a start of an exciting journey to bring us closer together as one organization and a team and to synergistically combine our complementary competences and expertise. We look forward to offering our HMO portfolio and integrating it in our full solutions offering for DSM’s broad and global Early Life Nutrition and Dietary Supplements customer base.

 

 

DSM – Bright Science. Brighter Living.™

Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

Share With:
Rate This Article

admin@medicareinsight.in

No Comments

Leave A Comment